The smart insulin pens market is projected to reach USD 4,606.3 million by 2025 and is expected to grow steadily at a CAGR of 8.3% to reach USD 10,224.3 million by 2035. In 2024, the smart insulin ...

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless non-patented drugmakers such as Biocon Ltd. step in to plug the gap in a ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

For over 20 years, Betsy Chadwell carried her insulin pens everywhere. Day in and day out, she carefully calibrated the doses needed to keep her Type 2 diabetes in check. “Every meal, and every ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections.

When you have gestational diabetes, you may need to take insulin to lower your blood sugar. It's safe to use and won't harm your baby.

The World Health Organization is delivering insulin pens to hospitals throughout Ukraine for those with diabetes as Russia continues its invasion.

The Swiss diabetes hardware company Ypsomed is selling off its insulin pen needle and blood sugar monitoring operations, as it turns its attention toward its drug autoinjectors and digital insulin ...

Few devices are more ubiquitous than insulin pens. About a third of the 37 million Americans with diabetes manage the disease with insulin, according to the Centers for Disease Control and Prevention.